Precision Monitoring Platform

About Okeiro

Okeiro is a Paris-based digital health company founded in 2019, focusing on precision medicine for transplant and chronic disease patients. Its core technology is a platform that integrates and analyzes patient data to provide predictive insights, notably through its iBox algorithm—an FDA and EMA-qualified biomarker for predicting long-term kidney graft survival. The company recently raised €10M in a Series A round (2025) to accelerate expansion, supporting its commercial rollout to healthcare professionals and its partnerships with life sciences companies for clinical research acceleration.

Therapeutic Areas